Content production for a MedTech navigating CE marking — zero compliance flags

The bottleneck

Marketing wanted to publish thought leadership and product-adjacent content during the regulatory window. Legal and regulatory wanted final review on anything that touched the product. The result was a queue where content sat for three weeks before being approved or spiked — and a marketing calendar that was always three weeks behind.

What we did

Restructured the approval workflow: claims language was reviewed and banked quarterly, and new content was written within the approved claims set. Anything requiring a novel claim went through a fast-track two-day review. The content calendar never waited on a cold-start legal review again.